Factors Associated With Post-Covid Conditions in Nangrong Hospital, Buriram province
Article Sidebar
Main Article Content
Abstract
Background: Outbreak of covid causing Post - COVID conditions with multiple systemic symptoms. However, even if the infection was cured. Some patients may have symptoms that deteriorated the quality of life after infection with coronavirus. At present, it is not clearly known how to prevent Post-COVID conditions.
Objective: Identifying factors associated with Post - COVID conditions in Nangrong Hospital, Buriram Province.
Study design: Retrospective cohort.
Methods: Two types of study models were used, descriptive study and analytical study. To determine the relationship of factors affecting the incidence of Post-COVID conditions by collecting data from patients diagnosed with Covid infection at Nang Rong Hospital from 1st April 2022 – 31st May 2022.
Results: 514 patients were collected, 51.9% of patients were classified as Post-COVID conditions. The most common symptoms were fatigue, Dyspnea, cough, and insomnia, mean of duration 10.5 weeks. Univariate significant factors associated with Post-COVID conditions were female gender (Relative Risk=1.28, 95%CI= 1.06 - 1.54, p-value = 0.007), hospital admission (Relative Risk =1.26, 95%CI= 1.05-1.50 p-value = 0.015), anxiety mood during the infection period (Relative Risk =1.33, 95%CI = 1.12-1.56 p-value = 0.002), history of allergy (Relative Risk =1.42, 95%CI = 1.21-1.67 p-value = 0.000), comorbidities with lung diseases (Relative Risk = 1.57, 95%CI= 1.24-1.99 p-value = 0.010), BMI < 18.5 (Relative Risk = 1.39, 95%CI= 1.05-1.82 p-value = 0.044) and covid pneumonia (Relative Risk =1.44, 95%CI= 1.19- 1.74 p-value = 0.002).
Conclusions: The multivariate significant factors were female gender, history of allergy, and comorbidities with lung diseases statistically significant.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization. Coronavirus Disease 2019(COVID-19): Situation Report, 51. Geneva : World Health Organization ; 2020.
เมธาวี หวังชาลาบวร, ศรัณย์ วีระเมธาชัย, ธนกมณ ลีศรี. ความชุกของภาวะหลังการติดเชื้อโควิด-19 ในผู้ป่วยที่มีประวัติ ติดเชื้อไวรัสโคโรนา 2019 จากการติดตามที่ระยะ 3 เดือนหลังการติดเชื้อ. วารสารศูนย์อนามัยที่ 9 2565;16(1):265-84.
ภัทิรา ตันติภาสวศิน, สิทธิชัย ตันติภาสวศิน. ภาวะโพสท์โควิด(ลองโควิด). วารสารโรงพยาบาลชลบุรี. 2565;47(1):67-84.
Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.J Infect Dis 2022;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, et al. Post COVID 19 Syndrome in Outpatients: a Cohort Study. J Gen Intern Med 2022;37(8):1943-52. doi: 10.1007/s11606-021-07242-1.
Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, et al. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov Ther 2021;15(5):254-60. doi: 10.5582/ddt.2021.01093.
Ziauddeen N, Gurdasani D, O'Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PLoS One 2022;17(3):e0264331. doi: 10.1371/journal.pone.0264331.
Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, et al. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front Pediatr 2022;10:894204. doi: 10.3389/fped.2022.894204.
Umesh A, Pranay K, Pandey RC, Gupta MK.Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection 2022;50(5):1053-66. doi: 10.1007/s15010-022-01835-6.
Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr 2021;15(3):869-75. doi: 10.1016/j.dsx.2021.04.007.
Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran J Med Sci 2021;46(6):428-36. doi: 10.30476/ijms.2021.92080.2326.
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med 2021;27(4):626-31. doi: 10.1038/s41591-021-01292-y.
Raj SVA, Jacob A, Ambu V, Wilson T, Renuka R. Post COVID-19 clinical manifestations and its risk factors among patients in a Northern District in Kerala, India. J Family Med Prim Care 2022;11(9):5312-9. doi: 10.4103/jfmpc.jfmpc_131_22.
Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022;28(8):1706-14. doi: 10.1038/s41591-022-01909-w.
Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med 2022;37(8):1988-95. doi: 10.1007/s11606-022-07523-3.
Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J 2022;59(2):2101341. doi: 10.1183/13993003.01341-2021.
Munblit D, Greenhawt M, Brough HA, Pushkareva A, Karimova D, Demidova A, et al. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol 2022;33(10):e13851. doi: 10.1111/pai.13851.
Rojas M, Rodríguez Y, Acosta-Ampudia Y, Monsalve DM, Zhu C, Li QZ, et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022 Mar 16;20(1):129. doi: 10.1186/s12967-022-03328-4.
Ciaffi J, Vanni E, Mancarella L, Brusi V, Lisi L, Pignatti F, et al. Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review. Diagnostics (Basel) 2023;13(11):1850. doi: 10.3390/diagnostics13111850.
Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.
Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022;28(7):1461-7. doi: 10.1038/s41591-022-01840-0
Herman B, Wong MC, Viwattanakulvanid P. Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study. PLoS One 2022;17(7):e0271385. doi: 10.1371/journal.pone.0271385.
Intharuksa A, Arunotayanun W, Yooin W, Sirisa-Ard P. A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery. Molecules 2022;27(14):4479. doi: 10.3390/molecules27144479.
Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg Health Eur 2021;11:100242. doi: 10.1016/j.lanepe.2021.100242.
Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022:2022.08.09.22278592. doi: 10.1101/2022.08.09.22278592.
Alkhathami MG, Advani SM, Abalkhail AA, Alkhathami FM, Alshehri MK, Albeashy EE, et al. Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis. Lung India 2021;38(Supplement):S31-S40. doi: 10.4103/lungindia.lungindia_497_20.
